| S1008: Exercise, Diet, & Counseling in Improving Weight Loss in Overweight Female Breast or Colorectal Cancer Survivors (NCT01453452) | SWOG Cancer Research Network | 2012-03-01 |
| An Observational Pilot Study Evaluating the Feasibility of Conducting Genome-Wide Association Studies Utilizing Subject Provided Information in Subjects With Locally Recurrent or MBC, MCRC, MNSCLC, RGBM or MRCC Treated With Avastin (Bevacizumab) (InVite) (NCT01598597) | Genentech, Inc. | 2012-03-01 |
| Uncovering Potential Breast Cancer Biomarkers Amp; Possible Drug Targets Using Advanced Quantitative Mass Spectrometry (NCT01619514) | National University Hospital, Singapore | 2012-03-01 |
| Diffusion Weighted Magnetic Resonance Imaging of the Breast During Chemotherapy: Response Evaluation (NCT01684735) | Universitaire Ziekenhuizen KU Leuven | 2012-03-01 |
| Inflammatory Response and Tissue Fibrosis/ Lymphatico-venous Bypass (NCT01433302) | M.D. Anderson Cancer Center | 2012-03-01 |
| Family Cancer Literacy to Promote Mammography Screening Among Navajo Women (NCT01605630) | Mayo Clinic | 2012-03-01 |
| A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy (NCT01611051) | Jiangsu HengRui Medicine Co., Ltd. | 2012-03-01 |
| Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim (NCT01516736) | Sandoz | 2012-03-01 |
| Maintenance Oral Vinorelbine or Observation After Vinorelbine-Docetaxel First Line Chemotherapy in Advanced Breast Ca (NCT02144194) | Cancer Research Group - Collaborative Group, Beirut, Lebanon. | 2012-03-01 |
| Study of Circulating and Tumor Biomarkers in Breast Cancer Patients (NCT01866202) | National University Hospital, Singapore | 2012-03-01 |
| Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty (NCT01553097) | Virginia Commonwealth University | 2012-03-01 |
| Telehealth System to Improve Quality of Life in Breast Cancer Survivors (NCT01801527) | Universidad de Granada | 2012-03-01 |
| Additional 4 Cycles of Cisplatin (CDDP4) in Patients With Triple Negative Breast Cancer for Neoadjuvant Chemotherapy (NCT02001519) | Asan Medical Center | 2012-03-01 |
| Long Term Outcomes of Breast Intensity-Modulated Radiation Therapy (NCT01537406) | British Columbia Cancer Agency | 2012-03-01 |
| Assessment of Substitution of Focused Cliches and Ultrasound for Tomosynthesis (NCT01612650) | Centre Oscar Lambret | 2012-02-24 |
| A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer (NCT01491737) | Hoffmann-La Roche | 2012-02-17 |
| Cancer Symptom Data From Multiple Treatment Centers (NCT01547845) | National Cancer Institute (NCI) | 2012-02-10 |
| Part II: Exercise in Hispanic Breast Cancer Survivors (NCT01504789) | M.D. Anderson Cancer Center | 2012-02-07 |
| Faslodex Specific Clinical Experience Investigation (NCT01501266) | AstraZeneca | 2012-02-01 |
| An Observational Time and Motion Study of Trastuzumab Subcutaneous (SC) and Intravenous (IV) Formulations in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (EBC) (NCT02658461) | Hoffmann-La Roche | 2012-02-01 |
| Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients (NCT01530373) | University of Arkansas | 2012-02-01 |
| The Efficacy of Health Partnership Program for Cancer Patients (NCT01527409) | National Cancer Center, Korea | 2012-02-01 |
| Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy (NCT01568346) | Dana-Farber Cancer Institute | 2012-02-01 |
| Studying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without Trastuzumab (NCT01562288) | Alliance for Clinical Trials in Oncology | 2012-02-01 |
| Study of Exercise to Manage Distress During Breast Screening (NCT02468050) | University of Western Ontario, Canada | 2012-02-01 |
| Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ (NCT01439711) | Alliance for Clinical Trials in Oncology | 2012-02-01 |
| Choices for Latinas and Clinical Trials (NCT02529280) | The University of Texas Health Science Center at San Antonio | 2012-02-01 |
| A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function (NCT01513083) | Hoffmann-La Roche | 2012-02-01 |
| Psycho-esthetic Impact of Tattoo Technology as Part of Mammary Reconstruction After Surgery Against Breast Cancer (NCT02464982) | University Hospital, Strasbourg, France | 2012-02-01 |
| HKI-272 for HER2-Positive Breast Cancer and Brain Metastases (NCT01494662) | Dana-Farber Cancer Institute | 2012-02-01 |
| Optimizing the Delineation of the Tumour Bed in Breast Irradiation (NCT02626858) | Universitaire Ziekenhuizen KU Leuven | 2012-02-01 |
| S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone Thpy (NCT01385137) | SWOG Cancer Research Network | 2012-02-01 |
| A Study to Correlate Ultrasound Elastography With Histopathology to Monitor the Response of Locally Advanced Breast Cancer to Neoadjuvant Chemotherapy (NCT01737970) | Oxford University Hospitals NHS Trust | 2012-02-01 |
| Intraoperative Radiation Therapy in Early Stage Breast Cancer (NCT02266602) | Benaroya Research Institute | 2012-02-01 |
| The HeartSpare Study (Stage I) (NCT02794324) | Royal Marsden NHS Foundation Trust | 2012-02-01 |
| Evaluation of Nutrition and Metabolism in Breast Cancer Patients (NCT01542216) | University of Waterloo | 2012-02-01 |
| Collection of FUJIFILM's 3Dimensional Mammograms (NCT01542814) | Fujifilm Medical Systems USA, Inc. | 2012-02-01 |
| Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide (NCT01537029) | Texas Tech University Health Sciences Center | 2012-02-01 |
| Integrated Molecular Profiling in Advanced Cancers Trial (NCT01505400) | University Health Network, Toronto | 2012-02-01 |
| Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix) (NCT01532232) | Memorial Sloan Kettering Cancer Center | 2012-02-01 |
| TKI258 for Metastatic Inflammatory Breast Cancer Patients (NCT01262027) | M.D. Anderson Cancer Center | 2012-01-27 |
| Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy (NCT01388777) | M.D. Anderson Cancer Center | 2012-01-24 |
| Using a Lay Health Worker Program to Increase Breast and Cervical Cancer Screening in Low-Income Hispanic Women (NCT04426019) | The University of Texas Health Science Center, Houston | 2012-01-12 |
| 4D Image-Guided Partial Breast Radiation in Stage 0 and l Breast Cancer (NCT01646346) | Yale University | 2012-01-10 |
| Testing a Spanish Version of a Patient Toxicity Questionnaire (NCT01517152) | National Cancer Institute (NCI) | 2012-01-04 |
| Preoperative Systemic Therapy vs Upfront Surgery in HER2 Positive Early Breast Cancer (NCT04249440) | Zhejiang Cancer Hospital | 2012-01-01 |
| Attention and Interpretation Modification (AIM) for Fear of Cancer Recurrence: An Intervention Development Study (NCT01517945) | Memorial Sloan Kettering Cancer Center | 2012-01-01 |
| BKM120 in Cancers With PIK3CA Activating Mutations (NCT01501604) | Massachusetts General Hospital | 2012-01-01 |
| Diagnosis and Prediction of Taxanes Induced Cardiac Dysfunction (NCT01641562) | Carol Davila University of Medicine and Pharmacy | 2012-01-01 |
| Oncotype DX in BRCA-mutated Breast Cancer Patients: Our Experience. A Retrospective Observational Monocentric Study (NCT06484725) | IRCCS San Raffaele | 2012-01-01 |
| Veliparib With Radiation Therapy in Patients With Inflammatory or Loco-regionally Recurrent Breast Cancer (NCT01477489) | University of Michigan Rogel Cancer Center | 2012-01-01 |
| The Role of the Novel 99mTc-NC100692 Tracer in Patients at High Risk or Known Breast Cancer (NCT01503697) | Tel-Aviv Sourasky Medical Center | 2012-01-01 |
| Treating Cancer-Related Fatigue Through Systematic Light Exposure (NCT01873794) | Icahn School of Medicine at Mount Sinai | 2012-01-01 |
| Internal Mammary Sentinel Lymph Node Biopsy in Early Breast Cancer Patients With Clinically Axillary Node -Negative (NCT01642511) | Shandong Cancer Hospital and Institute | 2012-01-01 |
| Integrative Approaches for Cancer Survivorship (NCT01488123) | University of California, San Francisco | 2012-01-01 |
| Research of Zoledronic Acid and Aromatase Inhibitors as Adjuvant Therapy to Breast Cancer (NCT01654367) | Tianjin Medical University | 2012-01-01 |
| A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer (NCT01423890) | Ontario Clinical Oncology Group (OCOG) | 2012-01-01 |
| Efficacy and Safety of TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Breast Cancer (NCT01648608) | Tianjin Medical University | 2012-01-01 |
| Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors (NCT01758146) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2012-01-01 |
| Endocrine Disruptors and Life STILe in Breast Cancer Development (NCT05748353) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2012-01-01 |
| Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast Cancer (NCT01647672) | Tianjin Medical University | 2012-01-01 |
| Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer (NCT01560663) | Miguel Martín Jiménez | 2012-01-01 |
| Comorbidities and Health Care Services Utilisation Among Long-term Breast Cancer Survivors (NCT03846999) | Parc de Salut Mar | 2012-01-01 |
| A Comparison of Recall Rates Between Conventional 2d Mammography and 2d Plus 3d (Tomosynthesis) Mammography in a Screening Population (NCT01569802) | Rose Imaging Specialists, P.A. | 2012-01-01 |
| Defining the Triple Negative Breast Cancer Kinome Response to GSK1120212 (NCT01467310) | UNC Lineberger Comprehensive Cancer Center | 2012-01-01 |
| The Diagnostic Technology Applied Research of CDK5RAP2 in Breast Cancer (NCT01634984) | Tianjin Medical University Cancer Institute and Hospital | 2012-01-01 |
| Long Term Follow-up of Persistent Pain, Sensory Disturbances and Lymphedema After Breast Cancer Treatment (NCT01543711) | Rigshospitalet, Denmark | 2012-01-01 |
| Evaluating the Adequacy of Giro-Couch to Support Prone Breast Boost Irradiation Using IMRT Technique With IGRT. (NCT01016574) | Azimuth Therapy Ltd. | 2011-12-01 |
| Study of Etoposide in Treating Patients With Recurrent or Metastatic Breast Cancer (NCT01492556) | Chinese Academy of Medical Sciences | 2011-12-01 |
| Tumor Suppressor Status as a Predictor of Chemotherapy Response in Triple Negative Breast Cancer (NCT01514565) | Thomas Jefferson University | 2011-12-01 |
| Evaluation of BIS for Quantification of Lymphedema (NCT01544335) | Massachusetts General Hospital | 2011-12-01 |
| Study of the Response to a Neoadjuvant Chemotherapy Based on the Antitumor Immune Response in Localized Breast Cancer (NCT01440413) | Centre Leon Berard | 2011-12-01 |
| The Effects of Pre-operative Physical Therapy Education (NCT01669187) | Oakland University | 2011-12-01 |
| The Memorial Sloan-Kettering Cancer Center (MSKCC (NCT01509963) | Assistance Publique - Hôpitaux de Paris | 2011-12-01 |
| Safety and Efficacy of BKM120 and Lapatinib in HER2+/PI3K-activated, Trastuzumab-resistant Advanced Breast Cancer (NCT01589861) | Institut Paoli-Calmettes | 2011-12-01 |
| Effect of Concomitant Radiotherapy and Trastuzumab on Cardiotoxicity of Patients Treated for Early Breast Cancer (NCT01572883) | Institute of Oncology Ljubljana | 2011-12-01 |
| Phase III Study Comparing the Efficacy and Safety of EP2006 and Filgrastim (NCT01519700) | Sandoz | 2011-12-01 |
| Feasibility Study for the Determination of Oxysterols in Patients With Breast Cancer Receiving Hormonal Therapy With Tamoxifen or Not (NCT01553903) | Institut Claudius Regaud | 2011-12-01 |
| Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial (NCT01528826) | Fudan University | 2011-12-01 |
| Therapy to Prevent Sexual Pain in Breast Cancer Survivors (NCT01539317) | OHSU Knight Cancer Institute | 2011-12-01 |
| Docetaxel With or Without Metronomic Cyclophosphamide as First Line Chemotherapy in Metastatic Breast Cancer (NCT01526499) | Fudan University | 2011-12-01 |
| Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis (NCT01701466) | Sir Mortimer B. Davis - Jewish General Hospital | 2011-12-01 |
| A Study of Herceptin (Trastuzumab) in Combination With Xeloda (Capecitabine) in Patients With Metastatic or Recurrent HER2-positive Breast Cancer After First-Line or (Neo)Adjuvant Therapy. (NCT01290718) | Hoffmann-La Roche | 2011-12-01 |
| Influence of the Superficial Inferior Epigastric System in Deep Inferior Epigastric Perforator (DIEP) Flaps (NCT01464970) | NHS Greater Glasgow and Clyde | 2011-12-01 |
| Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer (NCT01492543) | Chinese Academy of Medical Sciences | 2011-12-01 |
| Evaluation of the Predictive and Prognostic Value of Germ-line Polymorphisms in Patients With Metastatic Breast Cancer (NCT01460186) | Centre Leon Berard | 2011-12-01 |
| Low Dose of Metronomic Cyclophosphamide and Capecitabine in Pretreated HER2-negative Metastatic Breast Cancer (NCT01526512) | Fudan University | 2011-12-01 |
| Pre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast Cancer (NCT01502592) | Memorial Sloan Kettering Cancer Center | 2011-12-01 |
| A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer (NCT01358877) | Hoffmann-La Roche | 2011-11-08 |
| Breast Cancer Screening With MRI in Women Aged 50-75 Years With Extremely Dense Breast Tissue: the DENSE Trial (NCT01315015) | UMC Utrecht | 2011-11-01 |
| Neuropsychologic and Electrophysiological Features of Cancer-Related Cognitive Side Effects in Racial and Ethnic Minority Breast Cancer Patients (NCT01473680) | Memorial Sloan Kettering Cancer Center | 2011-11-01 |
| Effect of Cancer Nurse Navigators on Patient Outcomes (NCT01902823) | University of Wisconsin, Madison | 2011-11-01 |
| Ultrasound Paravertebral Block in Breast Surgery. (NCT01818817) | Campus Bio-Medico University | 2011-11-01 |
| Arm Circumference Measurement With or Without Bioimpedance Spectroscopy in Finding Lymphedema Early in Patients With Stage I-III Breast Cancer (NCT03648983) | Albert Einstein College of Medicine | 2011-11-01 |
| Feasibility Study on Stem Cells Sensitivity Assay (NCT01483001) | Associazione Oncologia Traslazionale | 2011-11-01 |
| Effectiveness and Toxicity of Gemcitabine/Lobaplatin Versus Gemcitabine/Cisplatin as Second-line Treatment in Metastatic Breast Cancer (NCT01483300) | Harbin Medical University | 2011-11-01 |
| Trial of Neoadjuvant EndoTAG-1 in Combination With Paclitaxel in HER2-negative Breast Cancer (NCT01537536) | Jules Bordet Institute | 2011-11-01 |
| Vitamin D and Breast Cancer: Does Weight Make a Difference? (NCT01472445) | Melinda Telli | 2011-11-01 |
| Patient Factors Impacting Adherence to Oral Chemotherapy (NCT01487343) | Memorial Sloan Kettering Cancer Center | 2011-11-01 |
| Cancer Stem Cell Biomarkers as a Predictor of Response to Trastuzumab in Samples From Patients With Breast Cancer Previously Treated in the NSABP-B-31 Trial (NCT01424865) | NSABP Foundation Inc | 2011-11-01 |